• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning

byConstance Wu
May 20, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Baricitinib reduces mortality risk in patients hospitalized with COVID-19

Heparin in noncritically ill COVID-19 patients [Classics Series]

Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response [Classics Series]

1. Following aggressive interventions across China since January 23, 2020, the confirmed case fatality risk in mainland China was 0.98%, five times smaller than that of Hubei, the epicenter of the COVID-19 spread.

 2. Relaxing restrictions and allowing the instantaneous reproduction number to rise above 1, even if restrictions were subsequently tightened, would likely still result in health and economic losses. 

Evidence Rating Level: 3 (Average)

Mainland China has observed 13,415 confirmed cases of COVID-19 and 120 deaths as of March 18, 2020. This is outside the epicenter of the virus outbreak in Hubei province. Massive non-pharmacological interventions were implemented across the country to reduce the spread, including a lockdown of Wuhan since January 23, 2020 along with 16 neighboring cities. This study provided an impact assessment of the severity and transmissibility of COVID-19 during the first wave in four cities (confirmed cases): Beijing (411), Shanghai (337), Shenzhen (417), and Wenzhou (504). Further, a susceptible-infectious-recovered model was used to simulate the potential effects of relaxing the interventions following the first wave. An instantaneous reproduction number (Rt) of COVID-19 was defined as the average number of secondary cases that one primary case could generate and derived from various databases from each city. Rt substantially decreased following the implementation of aggressive measures, keeping it steadily below 1. The confirmed case-fatality risk (cCFR) outside Hubei was 0.98% (95% CI 0.82 to 1.16), though the authors noted substantial heterogeneity across provinces such as Hubei (cCFR 5.91%, 95% CI 5.73 to 6.09) due to variable economies and healthcare resources. A susceptible-infectious-recovered model was used to simulate the potential effects of relaxing the interventions following the first wave. It was found that mainland China is capable of doing so very slowly, such that Rt will not exceed 1. As Rt is a function of time, quick relaxation of interventions or continuation of relaxation when the threshold had been breached resulted in a severe and exponential rise in COVID-19 cases. Relaxation should only be considered when the Rt is consistently <1 and can be kept at that level. Overall, the authors provide a basis upon which other countries with rising cases can learn, including not only aggressive measures to thwart the spread of the virus but very careful and slow relaxation of these interventions when the first wave subsides.

Click to read the study in Lancet

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chinaCoronavirusHubeiinstantaneous reproduction number SARS-CoV-2
Previous Post

School-based mental illness curriculum intervention can reduce stigma, increase rates of treatment among youth

Next Post

Atezolizumab-bevacizumab treatment increases survival in unresectable hepatocellular carcinoma

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Baricitinib reduces mortality risk in patients hospitalized with COVID-19

August 11, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
COVID-19 Classics

Heparin in noncritically ill COVID-19 patients [Classics Series]

July 17, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
COVID-19 Classics

Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response [Classics Series]

July 17, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
COVID-19 Classics

Interleukin-6 receptor antagonist treatment improves outcomes in patients with COVID-19 infection [Classics Series]

July 16, 2022
Next Post
Quick Take: Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study

Atezolizumab-bevacizumab treatment increases survival in unresectable hepatocellular carcinoma

Radiological findings of COVID-19 pneumonia in Wuhan, China

RT-PCR results during early SARS-CoV-2 infection course require cautious interpretation

#VisualAbstract: Association of childhood obesity with risk of early all-cause and cause-specific mortality

#VisualAbstract: Association of childhood obesity with risk of early all-cause and cause-specific mortality

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • LI-RADS outlines standards for liver imaging studies assessing HCC [Classics Series]
  • Daily disposable contact lenses may lower risk for Acanthamoeba keratitis
  • Vitamin D deficiency may be associated with sleep disorders in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.